SUG1 Antibodies

Santa Cruz Biotechnology provides a broad selection of SUG1 monoclonal antibodies for advanced research in molecular biology. SUG1 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SUG1, or SUG1 subunit of the 26S proteasome, plays a critical role in the regulation of protein degradation and is essential for maintaining cellular homeostasis. SUG1 is involved in various cellular processes, including the modulation of transcription and the response to stress, making it a significant target for understanding disease mechanisms. The study of SUG1 is particularly important in cancer research, where dysregulation of proteasomal activity can lead to tumor progression. Understanding SUG1's function has become increasingly important in developing targeted therapeutic approaches. Researchers worldwide rely on SUG1 monoclonal antibodies to advance their investigations into protein degradation pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers in their mission to uncover new insights into cellular processes and potential therapeutic targets.